Published in Ann Cardiol Angeiol (Paris) on February 01, 1992
Ischemia right ventricular dysfunction. Cardiovasc Drugs Ther (1994) 0.75
Effects of multisite biventricular pacing in patients with heart failure and intraventricular conduction delay. N Engl J Med (2001) 9.68
Long-term prognosis of patients diagnosed with Brugada syndrome: Results from the FINGER Brugada Syndrome Registry. Circulation (2010) 2.53
Four chamber pacing in dilated cardiomyopathy. Pacing Clin Electrophysiol (1994) 2.44
Multisite pacing as a supplemental treatment of congestive heart failure: preliminary results of the Medtronic Inc. InSync Study. Pacing Clin Electrophysiol (1998) 2.38
Permanent left ventricular pacing with transvenous leads inserted into the coronary veins. Pacing Clin Electrophysiol (1998) 2.27
Aneurysms and pseudoaneurysms of saphenous vein coronary artery bypass grafts. Heart (1998) 2.24
Hemodynamic importance of preserving the normal sequence of ventricular activation in permanent cardiac pacing. Am Heart J (1995) 2.15
Comparative effects of permanent biventricular and right-univentricular pacing in heart failure patients with chronic atrial fibrillation. Eur Heart J (2002) 1.97
Acute hemodynamic effects of biventricular DDD pacing in patients with end-stage heart failure. J Am Coll Cardiol (1998) 1.92
A pilot experience with permanent biventricular pacing to treat advanced heart failure. Am Heart J (2000) 1.78
Long-term effects of biatrial synchronous pacing to prevent drug-refractory atrial tachyarrhythmia: a nine-year experience. J Cardiovasc Electrophysiol (2000) 1.65
Optimal right ventricular pacing site in chronically implanted patients: a prospective randomized crossover comparison of apical and outflow tract pacing. J Am Coll Cardiol (1999) 1.53
The CARE-HF study (CArdiac REsynchronisation in Heart Failure study): rationale, design and end-points. Eur J Heart Fail (2001) 1.49
Combined antiplatelet therapy with ticlopidine and aspirin. A simplified approach to intracoronary stent management. Eur Heart J (1996) 1.47
Atrial fibrillation: current knowledge and recommendations for management. Working Group on Arrhythmias of the European Society of Cardiology. Eur Heart J (1998) 1.44
Incidence of paroxysmal atrial tachycardias in patients treated with cardiac resynchronization therapy and continuously monitored by device diagnostics. Europace (2010) 1.43
Electrocardiographic predictive factors of long-term clinical improvement with multisite biventricular pacing in advanced heart failure. Am J Cardiol (1999) 1.39
Physiological relationship between AV interval and heart rate in healthy subjects: applications to dual chamber pacing. Pacing Clin Electrophysiol (1986) 1.28
Pacemaker lead infection: echocardiographic features, management, and outcome. Heart (1999) 1.28
Effects of permanent dual-chamber pacing on mitral regurgitation in hypertrophic obstructive cardiomyopathy. Eur Heart J (1999) 1.22
Serum alpha-L-fucosidase: a new marker for the diagnosis of primary hepatic carcinoma? Hepatology (1984) 1.19
Familial form of arrhythmogenic right ventricular dysplasia. Am Heart J (1987) 1.16
Surgery for aortic stenosis in elderly patients. A study of surgical risk and predictive factors. Circulation (1994) 1.10
Mahaim tachycardias. Eur Heart J (1998) 0.99
Peripartum cardiomyopathy in the era of cardiac magnetic resonance imaging: first results and perspectives. Int J Cardiol (2009) 0.96
Preliminary clinical experience with the first dual chamber pacemaker defibrillator. Pacing Clin Electrophysiol (1997) 0.96
Comparative effects of permanent biventricular pacing for refractory heart failure in patients with stable sinus rhythm or chronic atrial fibrillation. Am J Cardiol (2000) 0.96
[Permanent atrial resynchronization by synchronous bi-atrial pacing in the preventive treatment of atrial flutter associated with high degree interatrial block]. Arch Mal Coeur Vaiss (1994) 0.94
Patient perspective on remote monitoring of cardiovascular implantable electronic devices: rationale and design of the REMOTE-CIED study. Neth Heart J (2014) 0.92
Baseline characteristics of patients recruited into the CARE-HF study. Eur J Heart Fail (2005) 0.92
Retrieval of a lost coronary stent from the descending aorta using a PTCA balloon and biopsy forceps. Cathet Cardiovasc Diagn (1993) 0.91
[Cardiac tuberculoma; value of echocardiography and therapeutic management apropos of a case]. Arch Mal Coeur Vaiss (1995) 0.90
Junctional rhythm during slow pathway radiofrequency ablation in patients with atrioventricular nodal reentrant tachycardia: beat-to-beat analysis and its prognostic value in relation to electrophysiologic and anatomic parameters. J Cardiovasc Electrophysiol (2000) 0.89
Permanent left atrial pacing with a specifically designed coronary sinus lead. Pacing Clin Electrophysiol (1997) 0.88
Endocarditis due to Fusarium dimerum four years after coronary artery bypass grafting. Clin Infect Dis (1999) 0.88
Clustering follow-up time-series recorded by cardiac implantable devices. Conf Proc IEEE Eng Med Biol Soc (2007) 0.88
Optimal algorithm switching for the estimation of systole period from cardiac microacceleration signals (SonR). IEEE Trans Biomed Eng (2012) 0.86
Homozygotes for a R869G mutation in the beta -myosin heavy chain gene have a severe form of familial hypertrophic cardiomyopathy. J Mol Cell Cardiol (2000) 0.85
Prospective evaluation of coronary arteries: influence on operative risk in coronary artery surgery. Eur J Cardiothorac Surg (1999) 0.83
Failure of the exercise test to predict the anterograde refractory period of the accessory pathway in Wolff Parkinson White syndrome. Pacing Clin Electrophysiol (1988) 0.83
Contribution of cardiac MRI in the comprehension of peripartum cardiomyopathy pathogenesis. Int J Cardiol (2008) 0.83
Stent placement compared with balloon angioplasty for small coronary arteries: in-hospital and 6-month clinical and angiographic results. Circulation (2001) 0.82
Haemodynamic benefit of a rate-adapted A-V delay in dual chamber pacing. Eur Heart J (1989) 0.82
[Infections on permanent endocavitary pacemaker leads: value of transesophageal echocardiography]. Arch Mal Coeur Vaiss (1995) 0.82
[Torsade de pointes. Apropos of 54 cases]. Ann Fr Anesth Reanim (1982) 0.81
Functional dissociation of cellular activation as a mechanism of Mobitz type II atrioventricular block. Circulation (1993) 0.80
Randomised comparison of coronary stenting with and without balloon predilatation in selected patients. Heart (2001) 0.80
[Importance of atrioventricular synchrony in hypertrophic obstructive cardiomyopathy treated by cardiac pacing]. Arch Mal Coeur Vaiss (1995) 0.79
[Value of the association of D-dimer measurement and the evaluation of clinical probability in a non-invasive diagnostic strategy of pulmonary embolism]. Arch Mal Coeur Vaiss (2004) 0.79
Lack of physiological adaptation of the atrioventricular interval to heart rate in patients chronically paced in the AAIR mode. Pacing Clin Electrophysiol (1991) 0.79
Benefits and limits of selective right ventricular cineangiography in arrhythmogenic right ventricular dysplasia. Eur Heart J (1989) 0.79
Early versus late coronary stenting following acute myocardial infarction: results of the STENTIM I Study (French Registry of Stenting in Acute Myocardial Infarction). Cathet Cardiovasc Diagn (1997) 0.78
[AFFIRM: what we have learned ... and pending issues]. Ann Cardiol Angeiol (Paris) (2005) 0.78
Coronary angioplasty is associated with a better neurological outcome in the era of modern management of out-of-hospital cardiac arrest. Int J Cardiol (2013) 0.78
[Prospective study of the diagnostic and prognostic criteria of right ventricular involvement in the acute phase of inferoposterior infarction]. Arch Mal Coeur Vaiss (1983) 0.78
Transvenous low energy internal cardioversion for atrial fibrillation refractory to external cardioversion: do non-obese patients benefit? Heart (2004) 0.78
Evaluation of bepridil efficacy by electrophysiologic testing in patients with recurrent ventricular tachycardia: comparison of two regimens. Cardiovasc Drugs Ther (1992) 0.77
Can peripartum cardiomyopathy be familial? Int J Cardiol (2008) 0.77
Early and late cardiac ventricular reverse remodeling after catheter ablation for lone paroxysmal atrial fibrillation. Ann Cardiol Angeiol (Paris) (2010) 0.77
Comparative effects of ventricular resynchronization therapy in heart failure patients with or without coronary artery disease. Ann Cardiol Angeiol (Paris) (2004) 0.77
[Value of serum myoglobin in acute myocardial infarction. Kinetic study]. Arch Mal Coeur Vaiss (1981) 0.77
[Indications for implantable automatic ventricular defibrillators. A report from the Heart Rhythm Group of the French Society of Cardiology]. Arch Mal Coeur Vaiss (2006) 0.76
[Mid-term outcome of acute right ventricular dysfunction in biventricular myocardial infarction. Hemodynamic and cineangiographic studies]. Arch Mal Coeur Vaiss (1987) 0.76
[Evaluation of coronary lesions in biventricular inferoposterior infarction]. Arch Mal Coeur Vaiss (1986) 0.76
[Incidence and prognosis of right ventricular involvement in the acute phase of myocardial infarction]. Arch Mal Coeur Vaiss (1980) 0.76
[Is isolated atrial fibrillation genetically determined? Apropos of a familial history]. Arch Mal Coeur Vaiss (1996) 0.75
Not too late, not too fast!! Eur Heart J (2009) 0.75
Dietary prevention of sudden cardiac death. Eur Heart J (2002) 0.75
Are electronic cardiac devices still evolving? Yearb Med Inform (2014) 0.75
Upgrading from ventricular to physiological pacing: is it worth it? Eur Heart J (2002) 0.75
Atrial pacing for the prevention of postoperative atrial fibrillation: how and where to pace? J Am Coll Cardiol (2000) 0.75
Influence of conduction time intervals on symptoms and exercise tolerance in patients with heart failure with left ventricular systolic dysfunction. Heart (2005) 0.75
Characteristics and outcome in arrhythmogenic right ventricular dysplasia. Am J Cardiol (1995) 0.75
[Infarction of the right ventricle]. Ann Cardiol Angeiol (Paris) (1984) 0.75
[Immediate and long-term results of 790 mitral valve replacements]. Arch Mal Coeur Vaiss (1992) 0.75
Is polyurethane lead insulation still controversial? Pacing Clin Electrophysiol (1992) 0.75
[20 years of mitral valve replacement. Development of a patient profile and operative mortality]. Arch Mal Coeur Vaiss (1993) 0.75
[Myocardiopathies during pregnancy. Possible role of beta-mimetics]. Arch Mal Coeur Vaiss (1978) 0.75
[Complications of myocardial infarction. Diagnosis, development, treatment]. Rev Prat (1995) 0.75
Failure of epinephrine to induce severe cardiac arrhythmia in rats with ventricular hypertrophy secondary to aortic pressure overload. Pharmacol Toxicol (1992) 0.75
[M-mode echocardiographic study of right ventricular involvement in the acute phase of inferoposterior myocardial infarction]. Arch Mal Coeur Vaiss (1983) 0.75